Regeneron Pharmaceuticals Inc (REGN)
744.50
+1.15
(+0.15%)
USD |
NASDAQ |
Nov 21, 16:00
739.61
-4.89
(-0.66%)
After-Hours: 06:29
Regeneron Pharmaceuticals Total Assets (Quarterly): 37.44B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 37.44B |
| June 30, 2024 | 36.09B |
| March 31, 2024 | 34.37B |
| December 31, 2023 | 33.08B |
| September 30, 2023 | 32.16B |
| June 30, 2023 | 30.66B |
| March 31, 2023 | 30.06B |
| December 31, 2022 | 29.21B |
| September 30, 2022 | 27.68B |
| June 30, 2022 | 27.21B |
| March 31, 2022 | 26.35B |
| December 31, 2021 | 25.43B |
| September 30, 2021 | 23.67B |
| June 30, 2021 | 21.49B |
| March 31, 2021 | 17.77B |
| December 31, 2020 | 17.16B |
| September 30, 2020 | 16.08B |
| June 30, 2020 | 14.43B |
| March 31, 2020 | 15.76B |
| December 31, 2019 | 14.81B |
| September 30, 2019 | 13.94B |
| June 30, 2019 | 13.17B |
| March 31, 2019 | 12.85B |
| December 31, 2018 | 11.73B |
| September 30, 2018 | 10.81B |
| Date | Value |
|---|---|
| June 30, 2018 | 9.952B |
| March 31, 2018 | 9.373B |
| December 31, 2017 | 8.764B |
| September 30, 2017 | 8.701B |
| June 30, 2017 | 8.106B |
| March 31, 2017 | 7.817B |
| December 31, 2016 | 6.973B |
| September 30, 2016 | 6.828B |
| June 30, 2016 | 6.205B |
| March 31, 2016 | 5.904B |
| December 31, 2015 | 5.609B |
| September 30, 2015 | 5.183B |
| June 30, 2015 | 4.527B |
| March 31, 2015 | 4.199B |
| December 31, 2014 | 3.838B |
| September 30, 2014 | 3.739B |
| June 30, 2014 | 3.456B |
| March 31, 2014 | 3.260B |
| December 31, 2013 | 2.951B |
| September 30, 2013 | 2.640B |
| June 30, 2013 | 2.378B |
| March 31, 2013 | 2.276B |
| December 31, 2012 | 2.080B |
| September 30, 2012 | 1.661B |
| June 30, 2012 | 1.458B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.43B
Minimum
Jun 2020
37.44B
Maximum
Sep 2024
25.55B
Average
26.78B
Median
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 90.88B |
| Eli Lilly and Co | 75.61B |
| Pfizer Inc | 219.48B |
| Biogen Inc | 28.31B |
| AbbVie Inc | 143.42B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.116B |
| Shareholders Equity (Quarterly) | 29.33B |
| Debt to Equity Ratio | 0.0677 |
| Current Ratio | 5.281 |
| Net Debt Paydown Yield | -0.00% |